Table 4 Baseline characteristics of individuals in the prospective cohort study

Patient status

 Age, years

61 (54, 65)

66.5 (59, 70.25)

63 (57, 68)

62 (55, 68)

<0.001* 0.023⁺

 Sex male, n (%)

650 (53.7%)

25 (69.4%)

247 (61.3%)

306 (61%)

<0.001* 0.598⁺

 Smoker, n (%)

284 (23.5%)

14 (38.9%)

122 (30.3%)

163 (32.5%)

<0.001* 0.504⁺

 SBP, mmHg

130 (120, 140)

140 (121.5, 160)

140 (126.5, 160)

148 (134, 163.5)

<0.001*< 0.001⁺

 DBP, mmHg

80 (74, 86)

80 (76.5, 90)

80 (78, 90)

90 (80, 100)

<0.001*<0.001⁺

 Hypertension, n (%)

308 (25.5%)

22 (61.1%)

223 (55.3%)

323 (64.3%)

<0.001* 0.022⁺

 Diabetes, n (%)

50 (4.1%)

3 (8.3%)

45 (11.2%)

54 (10.8%)

<  0.001* 0.868⁺

 CHD, n (%)

133 (11%)

4 (11.1%)

86 (21.3%)

113 (22.5%)

<  0.001* 0.272⁺

Fat indicators

 TC, mmol/L

5.06 (4.40, 5.70)

4.95 (4.17, 5.51)

4.80 (4.15, 5.45)

5.10 (4.40, 5.80)

0.122* 0.004⁺

 TG, mmol/L

1.40 (0.95, 1.90)

1.30 (0.95, 2.10)

1.50 (1.10, 2.10)

1.80 (1.30, 2.40)

< 0.001* < 0.001⁺

 HDL, mmol/L

1.24 (1.04, 1.46)

1.30 (1.03, 1.45)

1.18 (1.00, 1.38)

1.11 (0.96, 1.30)

< 0.001* 0.002⁺

 BFP, %

31.0 (26.0, 36.9)

21.1 (19.6, 26.0)

26.8 (23.5, 33.8)

32.9 (28.8, 39.6)

0.525* < 0.001⁺

Clinical outcomes

 Six months, n (%)

–

1 (2.78%)

9 (2.23%)

8 (1.59%)

0.727⁺

 One-year, n (%)

–

5 (13.9%)

20 (5%)

18 (3.6%)

0.015⁺

 Two-year, n (%)

–

8 (22.2%)

45 (11.2%)

40 (8%)

0.011⁺

 Three-year, n (%)

–

11 (30.6%)

82 (20.3%)

99 (19.7%)

0.297⁺

 Four-year, n (%)

–

14 (38.9%)

112 (27.8%)

147 (29.3%)

0.365⁺

 Five-year, n (%)

–

17 (47.2%)

122 (30.3%)

157 (31.3%)

0.110⁺

 RFS, week

–

46.2 (33.6, 63)

63 (44.4, 63)

63 (42, 63)

0.080⁺